News | June 06, 2014

Coquí to Build Medical Isotope Production Facility With Proven Technology

June 6, 2014 — Among the collection of aspiring medical isotope production companies looking to build facilities in the United States, Coquí RadioPharmaceuticals Corp. is he only one using a design and production method already proven in the commercial markets. Coquí is planning on constructing and operating a dedicated medical isotope production facility. In a recent letter to investors, Coquí noted that it is nearing completion of the Environmental Impact Study for the facility, which will pave the way to submit a construction permit application to the U.S. Nuclear Regulatory Commission in 2015.

Medical isotopes are used in a wide variety of medical tests, including cardiology stress tests and cancer screening. The most widely used medical isotope in the world is Technicium-99m (Tc-99m), which is derived from another isotope, Molybdenum-99 (Mo-99). Tc-99m is used in approximately 40,000 medical diagnostic procedures per day in the United States. With its short half-life, the isotope needs to be used in patients very quickly after it is created, but it is not produced in the United States.

International production sources tend to be older and frequently unreliable, which can delay delivery of potentially life-saving medical diagnostics and treatments to patients. International facilities also tend to use high-enriched uranium, which can raise proliferation concerns. “It is very important that proven technology be used because medical isotopes save lives. We know that the Coquí’s facility will bring a reliable domestic production source of these life-saving medical isotopes to the United States,” the CEO of Coquí, Carmen Bigles stated.

To implement this project Coquí has chosen INVAP, an internationally recognized Argentinian firm to design and construct the proposed facility, which will use low enriched uranium. INVAP has designed and constructed a number of similar facilities around the world, including the OPAL research reactor in Australia, the RA-3 in Argentina and others facilities that are successfully producing Mo-99 with low enriched uranium.

For more information: www.coquipharma.com

Related Content

ScImage and Invia Partnership Announced
News | Cardiac PACS| September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
CZT SPECT camera detectors offered by GE.

A display of CZT SPECT gamma camera detectors at RSNA 2016. These detectors are more sensitive than those used in older cameras, allowing for faster scans or lower radiation dose. 

Feature | Nuclear Imaging| September 19, 2017 | Dave Fornell
Cardiac nuclear myocardial perfusion imaging (MPI) has been a mature area of imaging for years, but has recently star
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging| September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
ARTMS Products Inc. and GE Healthcare Team Up to Expand Cyclotron-Produced Radioisotopes
News | Radiopharmaceuticals and Tracers| August 30, 2017
ARTMS Products Inc. signed a strategic partnership with GE Healthcare around ARTMS’ proprietary QUANTM99 Irradiation...
Sponsored Content | Videos | Nuclear Imaging| August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Sponsored Content | Videos | Nuclear Imaging| August 24, 2017
Randy Thompson, M.D., attending cardiologist, St.
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT| July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
Overlay Init